SC 13G: PLUS THERAPEUTICS, INC.
Ticker: PSTV · Form: SC 13G · Filed: Jun 5, 2024 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | SC 13G |
| Filed Date | Jun 5, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by PLUS THERAPEUTICS, INC..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G filing submitted by Plus Therapeutics, Inc. (ticker: PSTV) to the SEC on Jun 5, 2024.
What is the risk level of this SC 13G filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (f Securities: Common Stock, par value $0.001 per share (e) CUSIP Number: 72941H5).
How long is this filing?
Plus Therapeutics, Inc.'s SC 13G filing is 4 pages with approximately 1,174 words. Estimated reading time is 5 minutes.
Where can I view the full SC 13G filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,174 words · 5 min read · ~4 pages · Grade level 7.9 · Accepted 2024-06-05 07:26:01
Key Financial Figures
- $0.001 — f Securities: Common Stock, par value $0.001 per share (e) CUSIP Number: 72941H5
Filing Documents
- formsc13g.htm (SC 13G) — 88KB
- 0001493152-24-022638.txt ( ) — 90KB
(a) above and Item 4 of each cover page
Item 2(a) above and Item 4 of each cover page. (d) Title of Class of Securities: Common Stock, par value $0.001 per share (e) CUSIP Number: 72941H509 ITEM 3: IF THIS STATEMENT IS FILED PURSUANT TO §§240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution, in accordance with §240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ___________________________. ITEM 4: OWNERSHIP. See Item s 5,6,7,8 and 9 of each cover page. ITEM 5: OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ITEM 6: OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7: IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH AC